ZygoFix started its formal activity in January 2017 in the Trendlines Medical technology incubator, part of The Trendlines Group. It received investment and funding from Trendlines and the Israel Innovation Authority.
Over 10 years’ experience in the medical device industry as an engineer, product manager, and consultant; deep understanding of medical device development and lifecycle; MBA, Tel Aviv University, B.Sc., mechanical engineering, Ben-Gurion University of the Negev
Uri Arnin, Co-founder, CTO
Serial entrepreneur in the field of spinal implants; 30 years’ experience in medical device industry; 29 issued patents and 43 pending (all in spine); former CTO, Impliant (world’s first facet replacement device); CTO, Spine 21 (world’s first remote-controlled spinal implant); founder and CTO, ApiFix
Prof. Yizhar Floman, Co-founder, Medical Director
Chairman and Director, Israel Spine Center, Assuta Hospital, Tel Aviv; former Chief of Spine Surgery, Hadassah Hebrew University Medical Center, Jerusalem; President, Israel Orthopedic Association; member of numerous organizations, including Scoliosis Research Society, International Society for the Study of the Lumbar Spine, Spine Society of Europe, and the North American Spine Society
The company is funded by the Trendlines Group.
Nitza has 20 years of experience working in senior management positions at life science companies. Previously, she served as VP Business Development at TechnionSeed, the technological incubator founded by the Technion R&D Foundation 2, Ltd., where she was responsible for the life sciences and cleantech fields.
Previously, Nitza managed business development at Rafael Development Cooperation; served as CEO of Clal Life Sciences, an R&D center for emerging life science companies; and was CEO of UroGyn, a start-up that developed minimally invasive surgical tools.
Nitza earned her Ph.D. (life sciences) and M.Sc. from Tel Aviv University (both with distinction) and studied law at Tel Aviv University. She was a postdoctoral fellow in the Department of Plant Genetics at the Weizmann Institute of Science.
Barak Singer has over 15 years of experience in management, business development, investment banking, and venture capital.
Barak held a number of senior management positions, including Managing Director, Co-Head of Investment Banking, and head of Healthcare at Tamir Fishman & Co., representing the Royal Bank of Canada’s (NYSE:RY) investment banking arm in Israel, RBC Capital Markets. He also served as VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix, VP Business Development at Xenia Venture Capital, and was a co-founder and CEO at Or Capital Healthcare Partners.
Barak received his LLB in law and B.A. in business (both with distinction) from the Interdisciplinary Center in Herzliya, Israel.